KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Tax Provisions: 2013-2025

Historic Tax Provisions for Neogenomics (NEO) over the last 13 years, with Sep 2025 value amounting to $740,000.

  • Neogenomics' Tax Provisions rose 593.33% to $740,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$522,000, marking a year-over-year increase of 75.20%. This contributed to the annual value of -$1.9 million for FY2024, which is 78.65% up from last year.
  • Latest data reveals that Neogenomics reported Tax Provisions of $740,000 as of Q3 2025, which was up 202.21% from -$724,000 recorded in Q2 2025.
  • Neogenomics' 5-year Tax Provisions high stood at $976,000 for Q1 2021, and its period low was -$5.7 million during Q2 2022.
  • Its 3-year average for Tax Provisions is -$981,455, with a median of -$724,000 in 2025.
  • In the last 5 years, Neogenomics' Tax Provisions slumped by 742.39% in 2021 and then surged by 593.33% in 2025.
  • Over the past 5 years, Neogenomics' Tax Provisions (Quarterly) stood at -$2.4 million in 2021, then fell by 16.03% to -$2.8 million in 2022, then skyrocketed by 66.16% to -$960,000 in 2023, then grew by 16.25% to -$804,000 in 2024, then soared by 593.33% to $740,000 in 2025.
  • Its Tax Provisions was $740,000 in Q3 2025, compared to -$724,000 in Q2 2025 and $266,000 in Q1 2025.